Founding partner at The Conscious Fund, a US$60 million fund in the psychedelic medicine space which has backed 14 of the leading companies in the sector.
Expertise includes psychedelic compounds, operating models, venture funding, growth and exit planning, as well as managing media and investor relations campaigns.
Created over $200 million in company valuations within the psychedelic world.
Holds a degree in law from the University College London.